RxDoctor Payments DataLook up a doctor →

Kimberly Combs, MD

Family Medicine · Lynchburg, VANPI 1174505945

Payments from drug & device makers

$25,614in general payments, 2019–2025

Across 1,430 payments — averaging $17.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$4K
  • AstraZeneca$3K
  • AbbVie$3K
  • Pfizer$2K
  • Johnson & Johnson$2K
  • Amgen$1K
  • plus $11K from 51 others

What the payments were for

  • Food & beverage$25,531100%
  • Education$830%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk206$3,605
AstraZeneca65$3,332
AbbVie(2 entities)194$2,798
Pfizer187$2,022
Johnson & Johnson71$1,579
Amgen96$1,498
Boehringer Ingelheim61$1,038
Lilly USA, LLC56$962
Abbott51$951
GSK57$796
Otsuka America Pharmaceutical, Inc.18$596
Biohaven Pharmaceuticals, Inc.30$525
Takeda Pharmaceuticals U.S.A., Inc.34$504
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC29$488
Dexcom, Inc.21$477
Astellas Pharma US Inc31$471
Amarin Pharma, Inc.19$303
Bayer17$292
Esperion Therapeutics, Inc.10$280
Exact Sciences10$240
Sanofi-aventis U.S. LLC13$201
Kowa Pharmaceuticals America, Inc.13$198
Merck12$195
Novartis12$172
Biohaven Pharmaceutical Holding Company Ltd.10$164
E.r. Squibb & Sons, L.L.C.12$161
Axsome Therapeutics, Inc.3$150
Lundbeck LLC7$134
Phathom Pharmaceuticals, Inc.8$132
Xeris Pharmaceuticals, Inc.6$100
Supernus Pharmaceuticals, Inc.4$99
Teva Pharmaceuticals USA, Inc.7$90
Eisai Inc.6$90
Currax Pharmaceuticals LLC6$83
Sanofi Pasteur Inc.6$82
Idorsia Pharmaceuticals US Inc5$73
Inspire Medical Systems, Inc.1$69
Insightec,inc1$69
Arbor Pharmaceuticals, Inc.4$61
Corcept Therapeutics3$57
Ironwood Pharmaceuticals, Inc3$54
Corium, LLC3$53
Impel Pharmaceuticals Inc.3$51
Neurocrine Biosciences, Inc.2$44
Sumitomo Pharma America, Inc.3$34
Antares Pharma, Inc.2$31
Tris Pharma Inc1$27
Nestle Healthcare Nutrition Inc.2$26
Sanofi1$24
Biogen1$21
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$20
Almatica Pharma LLC1$19
Ironshore Pharmaceuticals Inc.1$18
Boston Scientific1$16
Sunovion Pharmaceuticals Inc.1$16
AMAG Pharmaceuticals, Inc.1$14
Genentech USA, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,614 in reported general payments places this provider in the 95th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$408,580
Medicare patients
530
Services billed
15,330

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban142$135,754
OzempicSemaglutide81$116,902
Enbrel SureclickEtanercept11$84,778
JardianceEmpagliflozin80$81,750
MounjaroTirzepatide60$67,696
RybelsusSemaglutide35$44,895
FarxigaDapagliflozin Propanediol49$43,534
RexultiBrexpiprazole21$37,184
TrulicityDulaglutide18$30,868
UbrelvyUbrogepant13$17,397
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$17,372
Repatha SureclickEvolocumab25$15,062
Xigduo XrDapaglifloz Propaned/Metformin26$12,866
Breo ElliptaFluticasone/Vilanterol18$10,091
Lantus SolostarInsulin Glargine,hum.Rec.Anlog59$9,844

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$3,605$161,797116 claims
PfizerEliquis, Premarin, Paxlovid$2,022$146,921194 claims
Lilly USA, LLCMounjaro, Trulicity$962$98,56478 claims
Boehringer IngelheimJardiance, Combivent Respimat$1,038$89,13095 claims
AstraZenecaFarxiga, Symbicort$3,332$48,75071 claims
Otsuka America Pharmaceutical, Inc.Rexulti$596$37,18421 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$796$33,02052 claims
AbbVieUbrelvy, Synthroid$2,798$22,08159 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$504$9,69916 claims
Johnson & JohnsonXarelto$1,579$9,26411 claims
Kowa Pharmaceuticals America, Inc.Livalo$198$4,28313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Lynchburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →